FDA Inspection
Paradox IncParadox Inc – FDA Inspection, Sep 22, 2010
Record Details
This FDA Inspection record concerns Paradox Inc, with an inspection on September 22, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Paradox Inc
- Inspection Date
- September 22, 2010
- Product Type
- Drugs
View Company Profile
ID · d1dafb28-8a29-4fd4-a204-2d4580794d5e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 682254
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(c)Testing and standardization of standards et. al.
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.194(a)(2)Suitability of testing methods verified
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Paradox Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 11, 2024 | Not classified | Kansas City District Office | |
| August 4, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 27, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 2, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Paradox Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.